Incyte (INCY) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Incyte (INCY)

INCY 105.40

-2.6%

Nov 13 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: bob s who wrote (1053)	6/14/1999 2:43:00 PM
From: LLCF	Read Replies (1) of 3202

<Michael Murphy is recommending selling INCY due to the clouds over the next year or so. > He was pounding the table [buy] when it dipped below his "buy level" a while back [think it was mid-20's]. His negative points are: - doesn't see big pharma paying higher prices for the service [revenue growth] - temporarily saturated their customer base with no substantial sales increment in sight. - doesn't see Big Pharma paying up for their expanding amount of data. - Wall street hasn't forgiven INCY for last years decision to invest in the future. - unhappy with the departure of CFO Dinise Gilbert. Says he may be more positive in a few months when it's trading in the low teens. DAK

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next